Infinimmune
infinimmune.com
Biotech
Infinimmune develops human-derived antibody therapeutics by engineering rare antibodies proven by evolution. They target inflammatory diseases, advancing them into clinical settings.
Founded
2022
Total Funding
Tens of millions
Total Rounds
2
First Raise
Dec 6, 2022
Latest Raise
Aug 11, 2026
Get notified when Infinimmune and companies like it raise
New funding rounds in your inbox every week 路 No noise, all Signal.
Organization Chart
Founders and leadership hierarchy for this company.
Contact details require Sales or Enterprise
Open Roles
Loading open roles...
All Funding Rounds
Showing 1 of 2 rounds
| Date | Deal Type | Amount | Lead Investor |
|---|---|---|---|
| 8/11/2026 | |||
1 more funding round available
Upgrade to Premium to view all historical funding rounds
Company Performance Metrics
Premium Feature
Upgrade to Premium to view Capital Momentum Score and performance metrics
Infinimmune 路 Never miss the next round
Who's raising next?
New funding rounds in your inbox every week 路 Free